Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer model

BJU International

Volumn 106, Issue 1, 2010, Pages 121-127

  Kumano, Masafumi ^a   Miyake, Hideaki ^a   Terakawa, Tomoaki ^a   Furukawa, Junya ^a   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aurora A; Prostate cancer; RNA interference

Indexed keywords

AURORA A KINASE; CISPLATIN; DOCETAXEL; DOXORUBICIN; MESSENGER RNA; SHORT HAIRPIN RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSFECTION; GLEASON SCORE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RNA INTERFERENCE;

AGED; ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; TAXOIDS; TUMOR BURDEN; TUMOR CELLS, CULTURED;

EID: 77953206216     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.09047.x     Document Type: Article

References (22)

1. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001 2 : 21 32
2. Carmena M, Earnshaw WC. The cellular geography of aurora kinase. Nat Rev Mol Cell Biol 2003 4 : 842 854
3. Warner SL, Bearss DJ, Han H, Von Hoff DD. Targeting aurora-2 kinase in cancer. Mol Cancer Ther 2003 2 : 589 595
4. Isola JJ, Kallioniemi OP, Chu LW et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 1995 147 : 905 911
5. Zhou H, Kuang J, Zhong L et al. Tumor amplification kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998 20 : 189 193
6. Pihan GA, Wallace J, Zhou Y, Doxsey SJ. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 2003 63 : 1398 1404
7. Buschhorn HM, Klein RR, Chambers SM et al. Aurora-A over-expression in high-grade PIN lesions and prostate cancer. Prostate 2005 64 : 341 346
8. Lee EC, Frolov A, Li R, Ayala G, Greenberg NM. Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res 2006 66 : 4996 5002
9. Furukawa J, Miyake H, Takenaka A, Hara I, Fujisawa M. Persistent expression of Aurora-A after neoadjuvant hormonal therapy as a predictor of a poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer. BJU Int 2007 100 : 310 314
10. Kurahashi T, Muramaki M, Yamanaka K, Hara I, Miyake H. Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension. BJU Int 2005 96 : 895 899
11. Miyake H, Nelson C, Rennie PS, Gleave ME. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway. Endocrinology 2000 141 : 2257 2265
12. Miyake H, Hara I, Kurahashi T, Inoue TA, Eto H, Fujisawa M. Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR. Clin Cancer Res 2007 13 : 1192 1197
13. Miyake H, Yamanaka K, Muramaki M, Hara I, Gleave ME. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Neoplasia 2005 7 : 171 179 (Pubitemid 40315994)
14. Goepfert TM, Adigun YE, Zhong L, Gay J, Medina D, Brinkley WR. Centrosome amplification and overexpression of Aurora A are early events in rat mammary carcinogenesis. Cancer Res 2002 62 : 4115 4122
15. Kurahashi T, Miyake H, Hara I, Fujisawa M. Significance of Aurora-A expression in renal cell carcinoma. Urol Oncol 2007 25 : 128 133
16. Niu Y, Altuwaijri S, Lai KP et al. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci USA 2008 105 : 12182 12187
17. Zhou J, Giannakakou P. Targeting microtubules for cancer chemotherapy. Curr Med Chem 2005 5 : 65 71
18. Lee HH, Zhu Y, Govindasamy KM, Gopalan G. Downregulation of Aurora-A overrides estrogen-mediated growth and chemoresistance in breast cancer cells. Endocr Relat Cancer 2008 15 : 765 775
19. Tanaka E, Hashimoto Y, Ito T et al. The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma. Clin Cancer Res 2007 13 : 1331 1340
20. Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002 2 : 243 247
21. Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004 49 : 955 970
22. Qu Y, Zhang L, Mao M et al. Effects of DNAzymes targeting Aurora kinase A on the growth of human prostate cancer. Cancer Gene Ther 2008 15 : 517 525